2003
DOI: 10.1210/en.2003-0294
|View full text |Cite
|
Sign up to set email alerts
|

Estrogen and Progesterone Up-Regulate Glucose Transporter Expression in ZR-75-1 Human Breast Cancer Cells

Abstract: Breast cancer incidence increases in women receiving combined estrogen and progesterone therapy. Breast tumors show increased expression of the glucose transporter GLUT1. We determined the effect of these hormones on GLUT1-4 expression and deoxyglucose transport in ZR-75-1 breast cancer cells. Immunoblotting, immunocytochemistry, flow cytometry, and RT-PCR showed that GLUT1 expression is up-regulated by progesterone and, to a greater degree, combined therapy. GLUT2 expression is unaffected by hormonal treatmen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
48
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 46 publications
(53 citation statements)
references
References 24 publications
(26 reference statements)
5
48
0
Order By: Relevance
“…between sex steroids and glucose in lipogenic gene regulation in breast cancer cells [41]. We found CHREBP mRNA to be readily detectable in T47D breast cancer cells, but found no major induction of S14 or FAS mRNAs in response to increasing the glucose concentration in culture media from 5.5 to 27 mM, a stimulus that is sufficient for maximal induction of lipogenesis-related genes in hepatocytes [16].…”
Section: Discussionmentioning
confidence: 65%
“…between sex steroids and glucose in lipogenic gene regulation in breast cancer cells [41]. We found CHREBP mRNA to be readily detectable in T47D breast cancer cells, but found no major induction of S14 or FAS mRNAs in response to increasing the glucose concentration in culture media from 5.5 to 27 mM, a stimulus that is sufficient for maximal induction of lipogenesis-related genes in hepatocytes [16].…”
Section: Discussionmentioning
confidence: 65%
“…This theory is in line with clinical observations where estrogen therapy increased the incidence of endometrial cancer and that this increase in incidence was reduced when progesterone was added to the hormonal preparations (Smith et al 1975, Berger & Fowler 1997 and is also supported by the observation that GLUT1 is overexpressed in biopsies from cancers from the majority of estrogen and progesterone target tissues, such as breast, endometrium, cervix and ovary (Kang et al 2002, Medina & Owen 2002. Similar results are available which correlate hormonal effects on GLUT expression and glucose transport in ZR-75 breast cancer cells to breast cancer incidence (Medina et al 2003). Furthermore, overexpression of GLUT2 has not been reported in cancers originating from steroid hormone target tissues (Medina & Owen 2002), nor was an alteration in GLUT2 observed in Ishikawa cells in response to hormonal administration.…”
Section: Discussionmentioning
confidence: 72%
“…Cells were grown in DMEM/F12 media supplemented with 10% fetal bovine serum as previously published (Medina et al 2003). Briefly, depending on the experiment, cells were plated in tissue culture Petri dishes or 12-well plates (Nunc, Rochester, NY, USA), until 80% confluence, and then the medium was changed to DMEM/F12 medium containing 5% charcoal-treated serum for 24 h. Cells were divided into four groups: control, estrogen, progesterone and combined estrogen and progesterone.…”
Section: Cell Culture and Hormonal Treatmentmentioning
confidence: 99%
See 1 more Smart Citation
“…The level of rhoA mRNA was examined by RT-PCR, a simple method that is widely used for semi-quantitative measurement of mRNA levels (e.g., Niiro et al, 1997;Ma et al, 2002;Murray et al, 2002;Chen et al, 2003;Medina et al, 2003;Zhu et al, 2003). Briefly, cDNAs were prepared from the total RNA (0.5 µg) by using a Takara RNA PCR Kit (Ver.…”
Section: Reverse Transcription-polymerase Chain Reaction (Rt-pcr)mentioning
confidence: 99%